by Megan Redshaw, Childrens Health Defense:
The Defender’s COVID NewsWatch provides a roundup of the latest headlines related to the SARS CoV-2 virus, including its origins and COVID vaccines.
Business Insider reported:
A landmark Israeli trial is expected to show that four shots of vaccine didn’t stop infection by the Omicron variant, according to a study official.
While the extra dose — of either Pfizer or Moderna vaccine — seemed to have some effect, rates of infection in the study were not substantially different to those who had three doses of Pfizer, the study official said.
Gili Regev-Yochay, a lead investigator on the study, told reporters that “the vaccine is excellent against the Alpha and Delta,” but the study found that “for Omicron, it’s not good enough,” The Times of Israel reported Monday evening.